Acute Renal Failure

(1)   Introduction

Acute renal failure (ARF) means sudden reduction of kidney function, leading to bodily retention of nitrogenous wastes.  Suspect the diagnosis in the setting of elevated BUN (>20 mg/dl) and serum creatinine (rise of >1 mg/dL/day) with or without oliguria (urine output of <400 mL/day).  A wide variety of factors can underlie the development of ARF.  For purposes of diagnosis and treatment, these factors are classified as prerenal, postrenal, and intrinsic to the kidneys.

(2)   Prerenal Causes of ARF

ARF may result from decreased effective arterial blood volume (intravascular volume loss, extravascular volume loss, increased vascular capacity, or fluid shifts from intravascular to extravascular spaces), congestive heart failure, or physical obstruction of renal blood flow.

(a)   Excessive sweating.

(b)   Anaphylaxis.

(c)   CHF / cardiogenic shock.

(d)   Hemorrhage.

(e)   Ascites.

(f)    Sepsis

(g)   Vomiting/diarrhea.

(h)   Polyuria - diuretics, diabetes insipidus, diabetes mellitus.

(i)    Plasma loss - burns.

(j)    Anasarca from hypoalbuminemic states - cirrhosis, nephrotic syndrome.

(3)     Postrenal causes of ARF

(a)   Ureteral obstruction.

(1)   Internal - ureteral stones, bladder cancer, papillary necrosis.

(2)   External - retroperitoneal fibrosis or malignancy.

(b)     Atonic bladder.

(1)   Autonomic neuropathy.

(2)   Spinal cord lesions.

(c)     Bladder neck obstruction.

(1)   Prostatic hypertrophy or cancer.

(2)   Anticholinergic drugs - especially in the elderly patients.

(3)   Cervical cancer.

(4)     Intrinsic causes of ARF

(a)   Tubulointerstitial.

(1)   Acute tubular necrosis.

(a)   Ischemia.

(b)   Toxins.

(1)   Pigment - hemoglobin, myoglobin.

(2)   Antibiotics - aminoglycosides, amphotericin.

(3)   IV contrast agents.

(4)   Uric acid, hypercalcemia.

(5)   Heavy metals, solvents, anesthetics.

(2)     Allergic interstitial nephritis.

(3)     Pyelonephritis - rarely causes ARF.

(b)     Glomerulovascular.

(1)   Vasculitis - Wegener's granulomatosis, polyarteritis nodosa, Henoch-Schonlein purpura, Goodpasture's syndrome.

(2)   Glomerulonephritis - Poststreptococcal, SLE.

(3)   Embolic disease - bacterial endocarditis, cholesterol emboli.

(4)   Malignant hypertension, hemolytic - uremic syndrome, thrombotic thrombocytopenic purpura.

(5)     Clinical Findings

A thorough history and physical exam can aid in finding the underlying cause of ARF.

(a)   Orthostatic symptoms - dehydration, blood loss, autonomic insufficiency.

(b)   Orthopnea, postural nocturnal dyspnea, chest pain, ankle swelling - CHF, nephrotic syndrome.

(c)   Flank pain - stones, papillary necrosis, pyelonephritis, acute glomerulonephritis, arterial emboli, acute renal vein thrombosis.

(d)   Dysuria, urgency - pyelonephritis.

(e)   Incontinence - atonic bladder, bladder neck obstruction (overflow).

(f)    Hematuria - stones, vasculitis, glomerulonephritis, and cancer.

(g)   Anuria (<50 ml/urine/day) - renal artery occlusion, severe acute glomerulonephritis or vasculitis, ureteral or bladder outflow obstruction.
 

(6)   Examination of the Urine in ARF

A urinalysis can provide important clues to the etiology of ARF.

(a)   RBCs - stones, malignancy, glomerular disease.

(b)   RBC casts - glomerulonephritis, vasculitis.

(c)   WBCs - cystitis, glomerulonephritis.

(d)   WBC casts - pyelonephritis.

(e)   Eosinophils - allergic interstitial nephritis.

(f)    Tubular cell casts - acute tubular necrosis.

(g)   Crystals - stones, urate nephropathy.

(h)   Myoglobin/hemoglobin - on dipstick without hematuria: pigmenturia.

(i)     Protein on sulfosalicylic acid (SSA)>>dipstick: dysproteinemia (e.g., multiple myeloma).

(7)     Management Measures In ARF

(a)   Replace volume deficit and correct hypotension if prerenal.

(b)   Relieve any outflow obstruction.

(c)   All drug doses should be adjusted to the level of renal function.

(d)   Improve cardiac function.

(e)   Monitor fluid status - diuretics.

(f)    Hyperkalemia.

(1)   Dietary potassium restriction: 1.5 to 2.0 grams/day.

(2)   Avoid nonselective beta-blockers.

(3)   Calcium gluconate, 10% solution, 10-20 ml IV bolus. May be repeated in 5 minutes if ECG appearance does not improve.

(4)   Regular insulin 10 units + 50mL of 50% dextrose as IV bolus.

(5)   Albuterol (5mg/mL), 10-20 mg, nebulized over 10 minutes

(6)   Kayexalate - 15-30 grams in 50-100 ml of 20% sorbic, orally

(g)   Sodium Bicarbonate - not needed if >16mEq/L, if <16mEq/L, 32-650 mg TID PO

(h)   Nephrology consultation.

(8)   Specific Criteria for Dialysis in ARF

(a)   Uremic symptoms - severe nausea and vomiting pericardial friction rub.

(b)   Fluid overload - unmanageable with diuretics.

(c)   Severe hyperkalemia - K >6.5 mEq/L, ECG changes.

(d)   Severe acidosis - pH <7.2 untreatable with sodium bicarbonate.

(e)   Drug overdose - dialyzable drugs only:  Lithium, alcohols, salicylates, and theophylline.

(9)     Summary

Acute renal failure can arise from a multitude of causes. Differentiation among prerenal, postrenal, and intrinsic causes proves useful for diagnosis, therapy, and prognosis. Patients may present with many or none of the manifestations of either the cause or the effect of renal failure. With few clinical clues, physicians must recognize the common settings in which acute renal failure develops and must order appropriate tests promptly. With advanced renal disease, severe derangements may necessitate urgent intervention by the nephrologist to stabilize the patient.

 

 

 

 

Preface  ·  Administrative Section  ·  Clinical Section

The General Medical Officer Manual , NAVMEDPUB 5134, January 1, 2000
Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This web version of The General Medical Officer Manual, NAVMEDPUB 5134 is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy version, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense. All material in this version is unclassified. This formatting © 2006 Medical Education Division, Brookside Associates, Ltd. All rights reserved.

Home  ·  Textbooks and Manuals  ·  Videos  ·  Lectures  ·  Distance Learning  ·  Training  ·  Operational Safety  ·  Search


This website is dedicated to the development and dissemination of medical information that may be useful to those who practice Operational Medicine. This website is privately-held and not connected to any governmental agency. The views expressed here are those of the authors, and unless otherwise noted, do not necessarily reflect the views of the Brookside Associates, Ltd., any governmental or private organizations. All writings, discussions, and publications on this website are unclassified.

© 2006 Medical Education Division, Brookside Associates, Ltd. All rights reserved

Other Brookside Products

Contact Us

Advertise on this Site